Revision of gastrointestinal mesenchymal tumours with CD117
- 1 November 2004
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (9) , 959-962
- https://doi.org/10.1016/j.ejso.2004.05.018
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumorsWorld Journal of Gastroenterology, 2003
- Management of malignant gastrointestinal stromal tumoursThe Lancet Oncology, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- The histopathological differential diagnosis of gastrointestinal stromal tumoursJournal of Clinical Pathology, 2001
- Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Archiv, 2001
- Mesenchymal Tumors of the Gastrointestinal Tract: A Paradise For Acronyms (STUMP, GIST, GANT, and Now GIPACT), Implication of c-kit in Genesis, and Yet Another of the Many Emerging Roles of the Interstitial Cell of Cajal in the Pathogenesis of Gastrointestinal Diseases?Advances in Anatomic Pathology, 1999
- Gastrointestinal Stromal Tumors—Value of CD34 Antigen in their Identification and Separation from True Leiomyomas and SchwannomasThe American Journal of Surgical Pathology, 1995